241 related articles for article (PubMed ID: 9007722)
1. Bilioenteric anastomosis reverses hyperkinetic circulation in bile duct-ligated cirrhotic rats.
Jalink D; Urbanski SJ; Lee SS
J Hepatol; 1996 Dec; 25(6):924-31. PubMed ID: 9007722
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat.
Zimmermann H; Fellay M; Zimmermann A
J Hepatol; 1997 Jan; 26(1):158-66. PubMed ID: 9148007
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium.
Lee SS; Girod C; Braillon A; Hadengue A; Lebrec D
Am J Physiol; 1986 Aug; 251(2 Pt 1):G176-80. PubMed ID: 3740260
[TBL] [Abstract][Full Text] [Related]
4. Effects of portacaval shunting on hyperdynamic circulation in bile duct-ligated cirrhotic rats.
Wong J; Zhang Y; Lee SS
J Hepatol; 1997 Feb; 26(2):369-75. PubMed ID: 9059959
[TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats.
Lee SS; Sharkey KA
Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic features of advanced cirrhosis due to chronic bile duct ligation.
Katsuta Y; Zhang XJ; Ohsuga M; Akimoto T; Komeichi H; Shimizu S; Inami T; Miyamoto A; Satomura K; Takano T
J Nippon Med Sch; 2005 Aug; 72(4):217-25. PubMed ID: 16113492
[TBL] [Abstract][Full Text] [Related]
8. Reversibility of hepatic mitochondrial damage in rats with long-term cholestasis.
Krähenbühl L; Schäfer M; Krähenbühl S
J Hepatol; 1998 Jun; 28(6):1000-7. PubMed ID: 9672176
[TBL] [Abstract][Full Text] [Related]
9. The effects of nitric oxide synthase blockers on mesenteric blood flow with bile duct ligation.
Yuksel BC; Tanriverdi P; Ozel H; Avsar FM; Topaloglu S; Iskit AB
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxix-ccxxi. PubMed ID: 15244184
[TBL] [Abstract][Full Text] [Related]
10. Reversibility of cholestatic changes following experimental common bile duct obstruction: fact or fantasy?
Aronson DC; Chamuleau RA; Frederiks WM; Gooszen HG; Heijmans HS; James J
J Hepatol; 1993 Apr; 18(1):85-95. PubMed ID: 8340613
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of Salvia miltiorrhiza on cirrhotic rats.
Huang YT; Lee TY; Lin HC; Chou TY; Yang YY; Hong CY
Can J Physiol Pharmacol; 2001 Jul; 79(7):566-72. PubMed ID: 11478589
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y
Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286
[TBL] [Abstract][Full Text] [Related]
14. Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats.
Ackerman Z; Karmeli F; Amir G; Rachmilewitz D
J Hepatol; 1996 Apr; 24(4):478-86. PubMed ID: 8738735
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Croquet V; Moal F; Veal N; Wang J; Oberti F; Roux J; Vuillemin E; Gallois Y; Douay O; Chappard D; Calès P
J Hepatol; 2002 Dec; 37(6):773-80. PubMed ID: 12445418
[TBL] [Abstract][Full Text] [Related]
16. Chronic indomethacin treatment enhances the portal-systemic collateral vascular response to vasopressin in bile-duct ligated rats.
Huang HC; Wang SS; Chang CC; Lee FY; Chang FY; Lin HC; Hou MC; Lu RH; Lee SD
J Chin Med Assoc; 2007 Dec; 70(12):521-6. PubMed ID: 18194892
[TBL] [Abstract][Full Text] [Related]
17. Effects of superior mesenteric artery stenosis on splanchnic and systemic hemodynamics in conscious rats with biliary cirrhosis.
Yang S; Soubrane O; Cailmail S; Gaudin C; Moreau R; Belghiti J; Lebrec D
J Hepatol; 1995 Apr; 22(4):481-5. PubMed ID: 7665867
[TBL] [Abstract][Full Text] [Related]
18. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.
Bosch J; Enriquez R; Groszmann RJ; Storer EH
Hepatology; 1983; 3(6):1002-7. PubMed ID: 6629314
[TBL] [Abstract][Full Text] [Related]
19. Time course of collagen peak in bile duct-ligated rats.
Tarcin O; Basaranoglu M; Tahan V; Tahan G; Sücüllü I; Yilmaz N; Sood G; Snyder N; Hilman G; Celikel C; Tözün N
BMC Gastroenterol; 2011 Apr; 11():45. PubMed ID: 21527001
[TBL] [Abstract][Full Text] [Related]
20. Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation.
Ubeda M; Matzilevich MM; Atucha NM; García-Estañ J; Quesada T; Tang SS; Ingelfinger JR
Hepatology; 1994 Jun; 19(6):1431-6. PubMed ID: 8188173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
